Publication: Comparison of ivermectin and albendazole treatment for gnathostomiasis
| dc.contributor.author | Ponganant Nontasut | en_US |
| dc.contributor.author | Valai Bussaratid | en_US |
| dc.contributor.author | Sukvannee Chullawichit | en_US |
| dc.contributor.author | Nawarat Charoensook | en_US |
| dc.contributor.author | Kasidis Visetsuk | en_US |
| dc.contributor.other | Mahidol University | en_US |
| dc.date.accessioned | 2018-09-07T09:19:55Z | |
| dc.date.available | 2018-09-07T09:19:55Z | |
| dc.date.issued | 2000-06-01 | en_US |
| dc.description.abstract | Comparative treatment of ivermectin in 21 patients (Group 1) and albendazole in 49 patients (Group 2) of gnathostomiasis gave the cure at 95.2% and 93.8% respectively. The ELISA OD and eosinophil counts were reduction after treatment. Side effects in ivermectin were hypotention, dizziness, weakness and diuresis; and side effects of albendazole were nausia, dizziness and increased alkaline phosphatase in two cases. Ivermectin should be an effective drug againts gnathostomiasis and more convenient in treatment single dose. | en_US |
| dc.identifier.citation | Southeast Asian Journal of Tropical Medicine and Public Health. Vol.31, No.2 (2000), 374-377 | en_US |
| dc.identifier.issn | 01251562 | en_US |
| dc.identifier.other | 2-s2.0-0034202564 | en_US |
| dc.identifier.uri | https://repository.li.mahidol.ac.th/handle/20.500.14594/26225 | |
| dc.rights | Mahidol University | en_US |
| dc.rights.holder | SCOPUS | en_US |
| dc.source.uri | https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=0034202564&origin=inward | en_US |
| dc.subject | Medicine | en_US |
| dc.title | Comparison of ivermectin and albendazole treatment for gnathostomiasis | en_US |
| dc.type | Review | en_US |
| dspace.entity.type | Publication | |
| mu.datasource.scopus | https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=0034202564&origin=inward | en_US |